Text Size

Pulsed Dye Laser for the Psoriatic Nail

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Taipei Medical University WanFang Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01303185
First received: February 22, 2011
Last updated: February 23, 2011
Last verified: February 2011
History of Changes
  Purpose

The treatment options for nail psoriasis have been limited, and the management of nail psoriasis has been challenging for physicians.To evaluate the effect of pulsed dye laser (PDL) in the treatment of nail psoriasis.


Condition
Psoriatic Nail Dystrophy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Pulsed Dye Laser for the Psoriatic Nail

Resource links provided by NLM:

MedlinePlus related topics: Psoriasis
U.S. FDA Resources

Further study details as provided by Taipei Medical University WanFang Hospital:

Estimated Enrollment: 20
Study Start Date: January 2011
Estimated Study Completion Date: December 2011
Groups/Cohorts
Experimental Group
Control Group

Detailed Description:

Psoriatic nails of patient's right hand were treated using PDL (595 nm) .The pulsed duration is 1.5ms, the beam diameter is 7mm, and the laser energy is 8.0 to 10.0 J/cm2. The treatment course of pulse dye laser is once monthly for 6 months. Psoriatic nails of both hands are treated with Tazarotene cream for 6 months. Clinical efficacy is statistically evaluated according to Nail Psoriasis Severity Index (NAPSI) score differences between right and left hand one month after 3rd and 6th therapy.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Psoriatic nail patients

Criteria

Inclusion Criteria:

  • Psoriatic nail refractory to other topical and systemic treatment therapy
  • ≧ 16 years old

Exclusion Criteria:

  • Patient with pregnancy
  • Patient with photo sensitivity
  • Patient with severe wound around finger nails or paronychia
  • Patient with hypersensitivity to Tazarotene cream
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01303185

Locations
Taiwan
Taipei Medical University - WanFang Hospital
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
Principal Investigator: Ying-Yi Chiang Taipei Medical University WanFang Hospital
  More Information

No publications provided

Responsible Party: Ying-Yi Chiang, Department of Dermatology, WanFang Hospital
ClinicalTrials.gov Identifier: NCT01303185     History of Changes
Other Study ID Numbers: 99074
Study First Received: February 22, 2011
Last Updated: February 23, 2011
Health Authority: Taiwan: Department of Health

Keywords provided by Taipei Medical University WanFang Hospital:
Psoriatic Nail
Pulsed dye laser

ClinicalTrials.gov processed this record on May 23, 2013